The Cardiovascular Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cardiovascular technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This report contains over 2,000 links to online copies of actual cardiovascular deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
Published: March 2012
No. of Pages:769
Price: Single User License: US$ 2695 Corporate User License: US$ 4095
The Cardiovascular Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in cardiovascular partnering deals
Average deal terms for headline, upfront and royalty by stage of development
Cardiovascular partnering agreement structure
Cardiovascular partnering contract documents
Top cardiovascular deals by value
Most active cardiovascular dealmakers
Benefits
Cardiovascular Partnering Terms and Agreements provides the reader with the following key benefits:
Get all Reports of Medical Devices @ http://www.reportsnreports.com/market-research/medical-devices/
The report provides a detailed understanding and analysis of how and why companies enter cardiovascular partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors cardiovascular technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases do not.
This report contains over 2,000 links to online copies of actual cardiovascular deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
Cardiovascular Partnering Terms and Agreements Market
Published: March 2012
No. of Pages:769
Price: Single User License: US$ 2695 Corporate User License: US$ 4095
The Cardiovascular Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.
Trends in cardiovascular partnering deals
Average deal terms for headline, upfront and royalty by stage of development
Cardiovascular partnering agreement structure
Cardiovascular partnering contract documents
Top cardiovascular deals by value
Most active cardiovascular dealmakers
Benefits
Cardiovascular Partnering Terms and Agreements provides the reader with the following key benefits:
- In-depth understanding of cardiovascular deal trends since 2007
- Access to headline, upfront, milestone and royalty data
- Comprehensive access to over 2,000 actual cardiovascular contracts entered into by the world’s biopharma companies
- Detailed access to actual cardiovascular contracts enter into by the leading fifty bigpharma companies
- Insight into the terms included in a cardiovascular agreement, together with real world clause examples
- Understand the key deal terms companies have agreed in previous deals
- Undertake due diligence to assess suitability of your proposed deal terms for partner companies
Get all Reports of Medical Devices @ http://www.reportsnreports.com/market-research/medical-devices/
